Clinical Trial Update: Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treosulfan and fludarabine phosphate as conditioning before donor stem cell transplant in nonmalignant inherited disorders has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-neoplastic Hematologic and Lymphocytic Disorder

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)
• Treosulfan (treosulfan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Non-Neoplastic Hematologic and Lymphocytic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-08-13